🇺🇸 FDA

Intelligence · Clinical Pipeline

BEONE MEDICINES AUS Pipeline

All ClinicalTrials.gov programs at BEONE MEDICINES AUS — phase, modality, and trial IDs.

Programs
51

Quick answer

BEONE MEDICINES AUS has 51 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. A Multicenter, Open-Label, Phase 1a/b First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of BG-C0979 in Patients with Selected Advanced Solid Tumors

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumors

    phase 1 other active

    1 trial

  2. A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Selected Advanced or Metastatic Solid Tumors

    BEONE MEDICINES AUS PTY LTD

    Selected Advanced or Metastatic Solid Tumors

    phase 1 other active

    1 trial

  3. A Phase 1 Study of BGB-B3227 Alone and in Combination With Tislelizumab in Patients With Advanced or Metastatic Solid Tumors

    BEONE MEDICINES AUS PTY LTD

    Solid tumors

    phase 1 other active

    1 trial

  4. A Phase 1a/1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Antitumor Activity of BG-75202, Alone and in Combination with Other Agents in Patients with Advanced Solid Tumors

    BEONE MEDICINES AUS PTY LTD

    Advanced and Metastatic Solid tumors

    phase 1 other active

    1 trial

  5. A Phase 1a/1b Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of BG-60366 in Patients With EGFR-Mutant Non-Small Cell Lung Cancer

    BEONE MEDICINES AUS PTY LTD

    EGFR-Mutant Non-Small Cell Lung Cancer

    phase 1 other active

    1 trial

  6. A Phase 1a/1b Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of the CDK4 Inhibitor BGB-43395, Alone or as Part of Combination Therapies in Patients With Metastatic HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

    BEONE MEDICINES AUS PTY LTD

    Advanced or metastatic solid tumors including hormone receptor positive (HR+), human epidermal growth factor 2 negative (HER2-) breast cancer

    phase 1 other active

    1 trial

  7. A Phase 1a/1b Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BGB-53038, a Pan-KRAS Inhibitor, as Monotherapy or in Combinations in Patients With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification

    BEONE MEDICINES AUS PTY LTD

    Advanced or Metastatic Solid Tumors with KRAS Mutations or Amplifications

    phase 1 other active

    1 trial

  8. A Phase 1a/1b, Open-Label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BG-75098 Alone and in Combination With Other Agents in Patients With Advanced Solid Tumors

    BEONE MEDICINES AUS PTY LTD

    Advanced, metastatic or unresectable solid tumors

    phase 1 other active

    1 trial

  9. A Phase 1a/b Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of PRMT5 Inhibitor BGB-58067 Alone and in Combination with Anticancer Agents in Patients With Advanced Solid Tumors

    BEONE MEDICINES AUS PTY LTD

    Advanced, or metastatic solid tumors with methylthioadenosine phosphorylase (MTAP) homozygous deletion and/or lost MTAP protein expression

    phase 1 other active

    1 trial

  10. AMG 509

    BEONE MEDICINES AUS PTY LTD

    Prostate Cancer

    phase 1 small molecule active

    1 trial

  11. BG-60366

    BEONE MEDICINES AUS PTY LTD

    Non-Small Cell Lung Cancer

    phase 1 small molecule terminated

    1 trial

  12. BG-68501

    BEONE MEDICINES AUS PTY LTD

    Breast Cancer

    phase 1 small molecule active

    1 trial

  13. BG-71332

    BEONE MEDICINES AUS PTY LTD

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  14. BG-75098

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  15. BG-75202

    BEONE MEDICINES AUS PTY LTD

    Breast Cancer

    phase 1 small molecule active

    1 trial

  16. BG-89894

    BEONE MEDICINES AUS PTY LTD

    Advanced or Metastatic MTAP-deleted Solid Tumors

    phase 1 small molecule terminated

    1 trial

  17. BG-A3004

    BEONE MEDICINES AUS PTY LTD

    Skin Diseases

    phase 1 mab active

    1 trial

  18. BG-C0902

    BEONE MEDICINES AUS PTY LTD

    Solid Tumors

    phase 1 small molecule active

    1 trial

  19. BG-C0979

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  20. BG-C137

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  21. BG-C477

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  22. BG-C9074

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  23. BGB-11417

    BEONE MEDICINES AUS PTY LTD

    Mature B-cell Malignancies

    phase 1 small molecule active

    1 trial

  24. BGB-15025

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  25. BGB-16673

    BEONE MEDICINES AUS PTY LTD

    Chronic Spontaneous Urticaria

    phase 1 small molecule active

    1 trial

  26. BGB-16673

    BEONE MEDICINES AUS PTY LTD

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  27. BGB-21447

    BEONE MEDICINES AUS PTY LTD

    Relapsed Non-Hodgkin Lymphoma

    phase 1 small molecule active

    1 trial

  28. BGB-21447

    BEONE MEDICINES AUS PTY LTD

    Hormone-receptor-positive Breast Cancer

    phase 1 small molecule active

    1 trial

  29. BGB-24714

    BEONE MEDICINES AUS PTY LTD

    Solid Tumor, Adult

    phase 1 small molecule terminated

    1 trial

  30. BGB-26808

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  31. BGB-43395

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  32. BGB-45035

    BEONE MEDICINES AUS PTY LTD

    Healthy Participants

    phase 1 small molecule active

    1 trial

  33. BGB-53038

    BEONE MEDICINES AUS PTY LTD

    Metastatic Solid Tumors

    phase 1 small molecule active

    1 trial

  34. BGB-58067

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  35. BGB-58067

    BEONE MEDICINES AUS PTY LTD

    Glioblastoma (GBM)

    phase 1 small molecule active

    1 trial

  36. BGB-58067

    BEONE MEDICINES AUS PTY LTD

    Healthy Volunteers

    phase 1 small molecule active

    1 trial

  37. BGB-A3055

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule terminated

    1 trial

  38. BGB-B2033

    BEONE MEDICINES AUS PTY LTD

    Metastatic Hepatocellular Carcinoma

    phase 1 small molecule active

    1 trial

  39. BGB-B3227

    BEONE MEDICINES AUS PTY LTD

    Advanced Cancer

    phase 1 small molecule terminated

    1 trial

  40. BGB-B455

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  41. BGB-C354

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  42. BGB-R046

    BEONE MEDICINES AUS PTY LTD

    Solid Tumor

    phase 1 small molecule terminated

    1 trial

  43. Drug: BG-T187

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  44. IO-108

    BEONE MEDICINES AUS PTY LTD

    Solid Tumor, Adult

    phase 1 mab completed

    1 trial

  45. IO-108

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 mab completed

    1 trial

  46. IO-202

    BEONE MEDICINES AUS PTY LTD

    Solid Tumor, Adult

    phase 1 mab completed

    1 trial

  47. IO-202

    BEONE MEDICINES AUS PTY LTD

    AML With Monocytic Differentiation

    phase 1 mab completed

    1 trial

  48. Lifirafenib

    BEONE MEDICINES AUS PTY LTD

    Solid Tumor, Adult

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does BEONE MEDICINES AUS have?

51 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.